|
AGPAT3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.27579999973516E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.943000E-03 |
| Normal-vs-Stage2 |
2.76880000005253E-06 |
| Normal-vs-Stage3 |
2.3540000004818E-07 |
| Normal-vs-Stage4 |
8.50210013503272E-10 |
| Stage1-vs-Stage2 |
2.469800E-02 |
| Stage1-vs-Stage3 |
1.545910E-02 |
| Stage1-vs-Stage4 |
1.93490000000018E-05 |
| Stage2-vs-Stage3 |
8.653400E-01 |
| Stage2-vs-Stage4 |
1.450400E-01 |
| Stage3-vs-Stage4 |
7.113900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19220000538434E-09 |
| Normal-vs-AfricanAmerican |
4.864200E-01 |
| Normal-vs-Asian |
1.266610E-01 |
| Caucasian-vs-AfricanAmerican |
6.550300E-02 |
| Caucasian-vs-Asian |
7.730000E-01 |
| AfricanAmerican-vs-Asian |
5.730400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.41129999908784E-08 |
| Normal-vs-Female |
1.734030E-02 |
| Male-vs-Female |
1.386650E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.878400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.858499999567E-07 |
| Normal-vs-Age(61-80Yrs) |
9.27479999468517E-08 |
| Normal-vs-Age(81-100Yrs) |
1.018850E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.173400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.417000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.728800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.477800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.288200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.137400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.654000E-01 |
| Normal-vs-Grade 2 |
1.218220E-03 |
| Normal-vs-Grade 3 |
1.98459999989353E-07 |
| Normal-vs-Grade 4 |
3.7627012616781E-11 |
| Grade 1-vs-Grade 2 |
1.992780E-01 |
| Grade 1-vs-Grade 3 |
2.418500E-02 |
| Grade 1-vs-Grade 4 |
1.012190E-02 |
| Grade 2-vs-Grade 3 |
9.998000E-02 |
| Grade 2-vs-Grade 4 |
2.59849999995065E-06 |
| Grade 3-vs-Grade 4 |
8.035700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.719900E-03 |
| Normal-vs-ccB subtype |
1.84580000173185E-08 |
| ccA subtype-vs-ccB subtype |
4.77609999993689E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62950000004436E-06 |
| Normal-vs-N1 |
5.300300E-03 |
| N0-vs-N1 |
6.646000E-01 |
|
|
